Downloading...
Download

XLV

SPX - Are you catching the rotation trends? SPX is still holding very bullish price action. Technicals are pointing towards higher price and todays inside consolidation day certainly helps digest recent gains. Along with the flat indices market session, we did observe some massive capital rotation trends. Financials saw a pretty strong down move across the board. JPM / BAC / C all saw large outflows. We were positioned on the short side of financials and took profits on JPM puts. Even with the big selloff in financials, SPX held up surprisingly well. Capital simply rotated instead of outright leaving the market. Bullish Signal. Technology, Energy, Materials, Health care, Transports all saw capital inflow trends. Rotation into under preforming sectors is a sign that markets could be staging another healthy leg up. We still have an upside target over 6300 on SPX.
SP:SPXLong
by Trading-Capital
1
$ELV Earnings Preview: Oversold Potential + Key Metrics AheadEarnings Estimates: Analysts forecast an EPS of $3.82 for the upcoming quarter, indicating a 32% year-over-year decline. Revenue is projected at $44.67 billion, a 5.2% increase from the same period last year. Oversold Potential: With an oversold score of 59%, NYSE:ELV appears attractive for accumulation. PEG Ratio: The PEG ratio stands at -0.77, suggesting undervaluation despite negative growth. Valuation Metrics: A forward P/E of 11.03, lower than the trailing P/E of 14.14, indicates potential undervaluation. Revenue Growth: Positive quarterly revenue growth estimates point to resilient performance. In the previous quarter, Elevance reported an EPS of $8.37, missing the consensus estimate of $9.66, but achieved a 5.3% year-over-year revenue increase to $44.72 billion. Guidance: In the previous quarter, Elevance Health revised its full-year 2024 adjusted EPS guidance downward to approximately $33, down from the prior estimate of $37.20, due to challenges in its Medicaid business. Despite these hurdles, Elevance's diversified portfolio and strategic initiatives position it for potential growth.
NYSE:ELV
by Solidified
TG Therapeutics forming 3rd baseIs a company that develops and commercializes novel treatments for B-cell diseases The stock initiated a bull trend at the end of 2023 after a breakaway gap and has gained +90% during 2024 and gave 2 opportunities to buy on breakouts Now is forming a 3rd base and may give another opportunity to enter, all this while relative to its sector AMEX:XLV is making new highs According to IBD is not among the industry leaders, but it has a 96 Relative Strength Rating against the SP:SPX
NASDAQ:TGTXLong
by dpuleo19
Healthcare Sector Poised For A 7% to 15% Rally Into Early 2025My continued research to help traders shows the US Healthcare and Biotech sectors are poised for a very large rally phase into early 2025. Particularly, XLV and XBI seem uniquely setup to rally more than 9-10% over the next 60 to 90+ days. This video explains how I use my Adaptive Dynamic Learning Predictive Modeling system to find opportunities other people miss. Using technology, predictive modeling, and inference engines like this is one advantage I have because I can build any type of technology or system I like - and use it on any symbol or interval I like. Now is the time to prepare for the big moves headed into 2025. Follow my research if you want to target the biggest price swings in the markets. Get some. #trading #research #investing #tradingalgos #tradingsignals #cycles #fibonacci #elliotwave #modelingsystems #stocks #bitcoin #btcusd #cryptos #spy #es #nq #gold
AMEX:XLVLong
by BradMatheny
Stock Market Analysis - Bullish & Bearish Sectors Heavy selling observed across the S&P500: Financials & Real Estate hit hard. S&P500 hitting the 50 day MA...technical daily support. Some breakout sectors are seeing there first pullback in a bullish trend. The sectors that have had breakouts will likely see dip buyers. Health Care & Utilities are into some interesting support levels. This is where bulls step in. Megacap Tech still saw some flight to safety money! Lets see if this holds.
TVC:US10Y
by Trading-Capital
HIMS a gender focused health care company LONGHIMS had an excellent earnings report for a small cap company; it is consumer driven quality focused and helps the customer feel good about him/her- self. It does not have any gender orientation agenda nor any obvious political inclinations. On the 120 minute chart, it started a moving averge convergence about a week before earnings. The Greeny TTM squeeze indicator did its thing as the post-earnings action began. I see this stock as a good long to hold into the next earnings and perhaps through it. HIMS is now at its all time high. There is no chart horizontal resistance overhead and traders will note that. I see the bullish momentum continuing perhaps with some healthy ( no pun intended) corrections while underway. Healthcare is considered to be a hot sector for 2024 this small cap seems to be warmed up.
NYSE:HIMSLong
by AwesomeAvani
The Healthcare Sector Index $XLV - Worth Watching SPDR Select Sector Fund – Healthcare Index AMEX:XLV The chart speaks for itself, we have our breakout levels and our break down levels. We enter on a breakout and set a stop 5% under that support and we exit and or short if we fall under the two underside support levels. Below I outline some reasons why the healthcare sector is worth paying attention too. The healthcare industry is worth $808 billion in the United States as of 2021. 65% of the industry’s revenue comes from patient care. The global healthcare industry is worth $12 trillion. In the U.S National health expenditures are projected to grow 5.4 percent, on average, over the course of 2023–31 and to account for roughly 20 percent of the economy by the end of that period. The insured share of the population is anticipated to exceed 92 percent through 2023 (figures pending), in part as a result of record-high Medicaid enrolment, and then decline toward 90 percent as coverage requirements related to the COVID-19 public health emergency expire. The growth of the health-care sector is evident in employment data as well. In 1990, about 8 million Americans worked in health care; that figure has since doubled to 16 million. That’s the largest single employment segment in our economy. In addition to the above, the west in general is an aging populace that is living longer. We will need these services more than we need staples during a recession. I believe this index can help us gauge the healthcare sector and what direction it will go next. We can watch the levels outlines and make a play if we wish. We have a hard upper boundary and lower boundary on a parallel channel on the chart. You know what to do when we breach any of these levels. Outlined on the chart XLV fund provides exposure to companies in pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology industries. XLV is the oldest in the segment, as such it is used widely for strategic or tactical positions. Since XLV is both cap weighted and fishes only from the S&P 500, it tilts heavily toward mega-caps. For focused exposure to leading health care names, XLV is tough to beat. Top Five Holdings UnitedHealth Group Inc NYSE:UNH 9.63% Eli Lilly and Co NYSE:LLY 9.19% Johnson & Johnson NYSE:JNJ 7.46% Merck & Co NYSE:MRK 5.46% AbbVie Inc 5.41% Stay Healthy and Nimble Folks PUKA
AMEX:XLV
by PukaCharts
XLV still coiling, possible double top on the daily? On the weekly timeframe XLV continues to coil. On the daily timeframe we may have seen a double top after the rejection at the bottom of the gap (136.50 area). FWIW these options can move, but they are low volume. On high momentum days trading the same week can be effective. Personally, I prefer to bid for calls on red days and puts on green days with swing trade straddle targets in mind. I'm currently eyeing the gap above but a breakdown with a stronger market pullback is possible. I will be looking to add a long swing position after the Jackson Hole / JPow speech depending on market conditions.
AMEX:XLV
by DVM2Trader